Master One Thing - Rapamycin Longevity Series

Rapamycin longevity series is about increasing our knowledge about this longevity compound together with scientists, physicians and other experts.

Joan Mannick on Rapamycin Longevity Series | Turning down mTOR to young levels may be good for aging
Jan 17, 2024 – 01:22:01
Brian Kennedy on Rapamycin Master Series | Aging is the biggest risk factor for age-related diseases
Oct 17, 2023 – 01:11:04
Mikhail Blagosklonny on Rapamycin Longevity Series | mTOR drives age-related diseases
Aug 22, 2023 – 01:42:07
Brad Stanfield on Rapamycin Longevity Series | Rapamycin, mTOR and the importance of muscle in life
Jul 11, 2023 – 01:15:52
Pankaj Kapahi on Rapamycin Longevity Series | There is no one size longevity intervention that fits all
Jun 14, 2023 – 01:08:01
Matt Kaeberlein on Rapamycin Longevity Series | Lessons learned from two decades of Rapamycin research
May 15, 2023 – 02:28:59
Alan Green on Rapamycin Longevity Series | Lessons learned from over 1200 patients
Apr 11, 2023 – 01:22:35
Ross Pelton on Rapamycin Longevity Series | How it all began
Mar 15, 2023 – 50:18